시장조사보고서

세계의 단클론 항체 매출 동향 2018 Global Monoclonal Antibodies Sales Market Report 2018

  • cover image
  • 상품 코드 : 375738
  • 리서치사 : QYResearch
  • 발행일 : 2018년 07월
  • 페이지 정보 : 영문 116 Pages
  • 배송 : 3~5 영업일 이내
  • 가격 :

요약

세계 시장의 단클론 항체 매출(소비) 동향을 조사했으며, 특히 주요 미국, 유럽, 중국, 일본, 동남아시아, 인도 기업의 매출, 가격, 수익, 시장 점유율에 관한 정보를 전해드립니다.

1 단클론 항체 시장 개요

2 세계 단클론 항체 시장의 경쟁 : 시장 진출기업/공급업체·종류·용도별

3 미국의 단클론 항체 (수량, 매출액, 판매가격)

4 유럽의 단클론 항체 (수량, 매출액, 판매가격)

5 중국의 단클론 항체 (수량, 매출액, 판매가격)

6 일본의 단클론 항체 (수량, 매출액, 판매가격)

7 동남아시아의 단클론 항체 (수량, 매출, 판매가격)

8 인도의 단클론 항체 (수량, 매출, 판매가격)

9 세계의 단클론 항체 시장 진출기업/공급업체 프로파일 및 매출 데이터

  • 9.1 AbbVie
  • 9.2 Roche
  • 9.3 Johnson & Johnson
  • 9.4 Amgen
  • 9.5 Merck
  • 9.6 BMS
  • 9.7 Eli Lilly
  • 9.8 Formation Biologics
  • 9.9 Genmab
  • 9.10 GlaxoSmithKline
  • 9.11 Human Genome Sciences
  • 9.12 mmunogen
  • 9.13 MedImmune
  • 9.14 Novartis
  • 9.15 Pfizer
  • 9.16 Seattle Genetics
  • 9.17 Stemcentrx
  • 9.18 Synthon Biopharmaceuticals
  • 9.19 Takeda
  • 9.20 Teva

10 단클론 항체 제조비용 분석

11 산업체인, 구매 전략, 다운스트림(Downstream) 구매자

12 마케팅 전략 분석 : 유통업체, 무역업체

13 시장 영향요인 분석

14 단클론 항체 세계 시장 예측 (2018-2025)

15 조사 결과와 결론

16 부록


목차

This report studies the global Monoclonal Antibodies market status and forecast, categorizes the global Monoclonal Antibodies market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins.

This treatment stimulates the immune system of patients to attack the foreign cells which cause the disease. Monoclonal antibodies are produced by using hybridoma technology. In hybridoma technology, the antibodies are obtained by fusion of human spleen cells and human myeloma. The characteristics of monoclonal antibodies which affect their efficacy are antigen specificity, overall structure and the affinity of the antibody for the target antigen or cells.

The global Monoclonal Antibodies market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major players covered in this report

  • AbbVie
  • Roche
  • Johnson & Johnson
  • Amgen
  • Merck
  • BMS
  • Eli Lilly
  • Formation Biologics
  • Genmab
  • GlaxoSmithKline
  • Human Genome Sciences
  • mmunogen
  • MedImmune
  • Novartis
  • Pfizer
  • Seattle Genetics
  • Stemcentrx
  • Synthon Biopharmaceuticals
  • Takeda
  • Teva

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

  • United States
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India

We can also provide the customized separate regional or country-level reports, for the following regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Singapore
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Central & South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • Turkey
    • Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

  • Cancer
  • Autoimmune Diseases
  • Infection
  • Hematological Diseases
  • Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

  • Oncology
  • Autoimmune and inflammatory diseases
  • Respiratory diseases
  • Ophthalmology

The study objectives of this report are:

  • To analyze and study the global Monoclonal Antibodies sales, value, status (2013-2017) and forecast (2018-2025);
  • To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
  • Focuses on the key Monoclonal Antibodies players, to study the sales, value, market share and development plans in future.
  • Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Monoclonal Antibodies are as follows:

  • History Year: 2013-2017
  • Base Year: 2017
  • Estimated Year: 2018
  • Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Monoclonal Antibodies Manufacturers

Monoclonal Antibodies Distributors/Traders/Wholesalers

Monoclonal Antibodies Subcomponent Manufacturers

Industry Association

Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Monoclonal Antibodies market, by end-use.

Detailed analysis and profiles of additional market players.

Table of Contents

1 Monoclonal Antibodies Market Overview

  • 1.1 Product Overview and Scope of Monoclonal Antibodies
  • 1.2 Classification of Monoclonal Antibodies by Product Category
    • 1.2.1 Global Monoclonal Antibodies Market Size (Sales) Comparison by Type (2013-2025)
    • 1.2.2 Global Monoclonal Antibodies Market Size (Sales) Market Share by Type (Product Category) in 2017
    • 1.2.3 Cancer
    • 1.2.4 Autoimmune Diseases
    • 1.2.5 Infection
    • 1.2.6 Hematological Diseases
    • 1.2.7 Others
  • 1.3 Global Monoclonal Antibodies Market by Application/End Users
    • 1.3.1 Global Monoclonal Antibodies Sales (Volume) and Market Share Comparison by Application (2013-2025)
    • 1.3.1 Oncology
    • 1.3.2 Autoimmune and inflammatory diseases
    • 1.3.3 Respiratory diseases
    • 1.3.4 Ophthalmology
  • 1.4 Global Monoclonal Antibodies Market by Region
    • 1.4.1 Global Monoclonal Antibodies Market Size (Value) Comparison by Region (2013-2025)
    • 1.4.2 United States Monoclonal Antibodies Status and Prospect (2013-2025)
    • 1.4.3 Europe Monoclonal Antibodies Status and Prospect (2013-2025)
    • 1.4.4 China Monoclonal Antibodies Status and Prospect (2013-2025)
    • 1.4.5 Japan Monoclonal Antibodies Status and Prospect (2013-2025)
    • 1.4.6 Southeast Asia Monoclonal Antibodies Status and Prospect (2013-2025)
    • 1.4.7 India Monoclonal Antibodies Status and Prospect (2013-2025)
  • 1.5 Global Market Size (Value and Volume) of Monoclonal Antibodies (2013-2025)
    • 1.5.1 Global Monoclonal Antibodies Sales and Growth Rate (2013-2025)
    • 1.5.2 Global Monoclonal Antibodies Revenue and Growth Rate (2013-2025)

2 Global Monoclonal Antibodies Competition by Players/Suppliers, Type and Application

  • 2.1 Global Monoclonal Antibodies Market Competition by Players/Suppliers
    • 2.1.1 Global Monoclonal Antibodies Sales and Market Share of Key Players/Suppliers (2013-2018)
    • 2.1.2 Global Monoclonal Antibodies Revenue and Share by Players/Suppliers (2013-2018)
  • 2.2 Global Monoclonal Antibodies (Volume and Value) by Type
    • 2.2.1 Global Monoclonal Antibodies Sales and Market Share by Type (2013-2018)
    • 2.2.2 Global Monoclonal Antibodies Revenue and Market Share by Type (2013-2018)
  • 2.3 Global Monoclonal Antibodies (Volume and Value) by Region
    • 2.3.1 Global Monoclonal Antibodies Sales and Market Share by Region (2013-2018)
    • 2.3.2 Global Monoclonal Antibodies Revenue and Market Share by Region (2013-2018)
  • 2.4 Global Monoclonal Antibodies (Volume) by Application

3 United States Monoclonal Antibodies (Volume, Value and Sales Price)

  • 3.1 United States Monoclonal Antibodies Sales and Value (2013-2018)
    • 3.1.1 United States Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    • 3.1.2 United States Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
    • 3.1.3 United States Monoclonal Antibodies Sales Price Trend (2013-2018)
  • 3.2 United States Monoclonal Antibodies Sales Volume and Market Share by Players (2013-2018)
  • 3.3 United States Monoclonal Antibodies Sales Volume and Market Share by Type (2013-2018)
  • 3.4 United States Monoclonal Antibodies Sales Volume and Market Share by Application (2013-2018)

4 Europe Monoclonal Antibodies (Volume, Value and Sales Price)

  • 4.1 Europe Monoclonal Antibodies Sales and Value (2013-2018)
    • 4.1.1 Europe Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    • 4.1.2 Europe Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
    • 4.1.3 Europe Monoclonal Antibodies Sales Price Trend (2013-2018)
  • 4.2 Europe Monoclonal Antibodies Sales Volume and Market Share by Players (2013-2018)
  • 4.3 Europe Monoclonal Antibodies Sales Volume and Market Share by Type (2013-2018)
  • 4.4 Europe Monoclonal Antibodies Sales Volume and Market Share by Application (2013-2018)

5 China Monoclonal Antibodies (Volume, Value and Sales Price)

  • 5.1 China Monoclonal Antibodies Sales and Value (2013-2018)
    • 5.1.1 China Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    • 5.1.2 China Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
    • 5.1.3 China Monoclonal Antibodies Sales Price Trend (2013-2018)
  • 5.2 China Monoclonal Antibodies Sales Volume and Market Share by Players (2013-2018)
  • 5.3 China Monoclonal Antibodies Sales Volume and Market Share by Type (2013-2018)
  • 5.4 China Monoclonal Antibodies Sales Volume and Market Share by Application (2013-2018)

6 Japan Monoclonal Antibodies (Volume, Value and Sales Price)

  • 6.1 Japan Monoclonal Antibodies Sales and Value (2013-2018)
    • 6.1.1 Japan Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    • 6.1.2 Japan Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
    • 6.1.3 Japan Monoclonal Antibodies Sales Price Trend (2013-2018)
  • 6.2 Japan Monoclonal Antibodies Sales Volume and Market Share by Players (2013-2018)
  • 6.3 Japan Monoclonal Antibodies Sales Volume and Market Share by Type (2013-2018)
  • 6.4 Japan Monoclonal Antibodies Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Monoclonal Antibodies (Volume, Value and Sales Price)

  • 7.1 Southeast Asia Monoclonal Antibodies Sales and Value (2013-2018)
    • 7.1.1 Southeast Asia Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    • 7.1.2 Southeast Asia Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
    • 7.1.3 Southeast Asia Monoclonal Antibodies Sales Price Trend (2013-2018)
  • 7.2 Southeast Asia Monoclonal Antibodies Sales Volume and Market Share by Players (2013-2018)
  • 7.3 Southeast Asia Monoclonal Antibodies Sales Volume and Market Share by Type (2013-2018)
  • 7.4 Southeast Asia Monoclonal Antibodies Sales Volume and Market Share by Application (2013-2018)

8 India Monoclonal Antibodies (Volume, Value and Sales Price)

  • 8.1 India Monoclonal Antibodies Sales and Value (2013-2018)
    • 8.1.1 India Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    • 8.1.2 India Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
    • 8.1.3 India Monoclonal Antibodies Sales Price Trend (2013-2018)
  • 8.2 India Monoclonal Antibodies Sales Volume and Market Share by Players (2013-2018)
  • 8.3 India Monoclonal Antibodies Sales Volume and Market Share by Type (2013-2018)
  • 8.4 India Monoclonal Antibodies Sales Volume and Market Share by Application (2013-2018)

9 Global Monoclonal Antibodies Players/Suppliers Profiles and Sales Data

  • 9.1 AbbVie
    • 9.1.1 Company Basic Information, Manufacturing Base and Competitors
    • 9.1.2 Monoclonal Antibodies Product Category, Application and Specification
      • 9.1.2.1 Product A
      • 9.1.2.2 Product B
    • 9.1.3 AbbVie Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
    • 9.1.4 Main Business/Business Overview
  • 9.2 Roche
    • 9.2.1 Company Basic Information, Manufacturing Base and Competitors
    • 9.2.2 Monoclonal Antibodies Product Category, Application and Specification
      • 9.2.2.1 Product A
      • 9.2.2.2 Product B
    • 9.2.3 Roche Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
    • 9.2.4 Main Business/Business Overview
  • 9.3 Johnson & Johnson
    • 9.3.1 Company Basic Information, Manufacturing Base and Competitors
    • 9.3.2 Monoclonal Antibodies Product Category, Application and Specification
      • 9.3.2.1 Product A
      • 9.3.2.2 Product B
    • 9.3.3 Johnson & Johnson Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
    • 9.3.4 Main Business/Business Overview
  • 9.4 Amgen
    • 9.4.1 Company Basic Information, Manufacturing Base and Competitors
    • 9.4.2 Monoclonal Antibodies Product Category, Application and Specification
      • 9.4.2.1 Product A
      • 9.4.2.2 Product B
    • 9.4.3 Amgen Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
    • 9.4.4 Main Business/Business Overview
  • 9.5 Merck
    • 9.5.1 Company Basic Information, Manufacturing Base and Competitors
    • 9.5.2 Monoclonal Antibodies Product Category, Application and Specification
      • 9.5.2.1 Product A
      • 9.5.2.2 Product B
    • 9.5.3 Merck Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
    • 9.5.4 Main Business/Business Overview
  • 9.6 BMS
    • 9.6.1 Company Basic Information, Manufacturing Base and Competitors
    • 9.6.2 Monoclonal Antibodies Product Category, Application and Specification
      • 9.6.2.1 Product A
      • 9.6.2.2 Product B
    • 9.6.3 BMS Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
    • 9.6.4 Main Business/Business Overview
  • 9.7 Eli Lilly
    • 9.7.1 Company Basic Information, Manufacturing Base and Competitors
    • 9.7.2 Monoclonal Antibodies Product Category, Application and Specification
      • 9.7.2.1 Product A
      • 9.7.2.2 Product B
    • 9.7.3 Eli Lilly Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
    • 9.7.4 Main Business/Business Overview
  • 9.8 Formation Biologics
    • 9.8.1 Company Basic Information, Manufacturing Base and Competitors
    • 9.8.2 Monoclonal Antibodies Product Category, Application and Specification
      • 9.8.2.1 Product A
      • 9.8.2.2 Product B
    • 9.8.3 Formation Biologics Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
    • 9.8.4 Main Business/Business Overview
  • 9.9 Genmab
    • 9.9.1 Company Basic Information, Manufacturing Base and Competitors
    • 9.9.2 Monoclonal Antibodies Product Category, Application and Specification
      • 9.9.2.1 Product A
      • 9.9.2.2 Product B
    • 9.9.3 Genmab Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
    • 9.9.4 Main Business/Business Overview
  • 9.10 GlaxoSmithKline
    • 9.10.1 Company Basic Information, Manufacturing Base and Competitors
    • 9.10.2 Monoclonal Antibodies Product Category, Application and Specification
      • 9.10.2.1 Product A
      • 9.10.2.2 Product B
    • 9.10.3 GlaxoSmithKline Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
    • 9.10.4 Main Business/Business Overview
  • 9.11 Human Genome Sciences
  • 9.12 mmunogen
  • 9.13 MedImmune
  • 9.14 Novartis
  • 9.15 Pfizer
  • 9.16 Seattle Genetics
  • 9.17 Stemcentrx
  • 9.18 Synthon Biopharmaceuticals
  • 9.19 Takeda
  • 9.20 Teva

10 Monoclonal Antibodies Maufacturing Cost Analysis

  • 10.1 Monoclonal Antibodies Key Raw Materials Analysis
    • 10.1.1 Key Raw Materials
    • 10.1.2 Price Trend of Key Raw Materials
    • 10.1.3 Key Suppliers of Raw Materials
    • 10.1.4 Market Concentration Rate of Raw Materials
  • 10.2 Proportion of Manufacturing Cost Structure
    • 10.2.1 Raw Materials
    • 10.2.2 Labor Cost
    • 10.2.3 Manufacturing Process Analysis of Monoclonal Antibodies
  • 10.3 Manufacturing Process Analysis of Monoclonal Antibodies

11 Industrial Chain, Sourcing Strategy and Downstream Buyers

  • 11.1 Monoclonal Antibodies Industrial Chain Analysis
  • 11.2 Upstream Raw Materials Sourcing
  • 11.3 Raw Materials Sources of Monoclonal Antibodies Major Manufacturers in 2017
  • 11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders

  • 12.1 Marketing Channel
    • 12.1.1 Direct Marketing
    • 12.1.2 Indirect Marketing
    • 12.1.3 Marketing Channel Development Trend
  • 12.2 Market Positioning
    • 12.2.1 Pricing Strategy
    • 12.2.2 Brand Strategy
    • 12.2.3 Target Client
  • 12.3 Distributors/Traders List

13 Market Effect Factors Analysis

  • 13.1 Technology Progress/Risk
    • 13.1.1 Substitutes Threat
    • 13.1.2 Technology Progress in Related Industry
  • 13.2 Consumer Needs/Customer Preference Change
  • 13.3 Economic/Political Environmental Change

14 Global Monoclonal Antibodies Market Forecast (2018-2025)

  • 14.1 Global Monoclonal Antibodies Sales Volume, Revenue and Price Forecast (2018-2025)
    • 14.1.1 Global Monoclonal Antibodies Sales Volume and Growth Rate Forecast (2018-2025)
    • 14.1.2 Global Monoclonal Antibodies Revenue and Growth Rate Forecast (2018-2025)
    • 14.1.3 Global Monoclonal Antibodies Price and Trend Forecast (2018-2025)
  • 14.2 Global Monoclonal Antibodies Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
    • 14.2.1 Global Monoclonal Antibodies Sales Volume and Growth Rate Forecast by Regions (2018-2025)
    • 14.2.2 Global Monoclonal Antibodies Revenue and Growth Rate Forecast by Regions (2018-2025)
    • 14.2.3 United States Monoclonal Antibodies Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
    • 14.2.4 Europe Monoclonal Antibodies Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
    • 14.2.5 China Monoclonal Antibodies Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
    • 14.2.6 Japan Monoclonal Antibodies Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
    • 14.2.7 Southeast Asia Monoclonal Antibodies Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
    • 14.2.8 India Monoclonal Antibodies Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  • 14.3 Global Monoclonal Antibodies Sales Volume, Revenue and Price Forecast by Type (2018-2025)
    • 14.3.1 Global Monoclonal Antibodies Sales Forecast by Type (2018-2025)
    • 14.3.2 Global Monoclonal Antibodies Revenue Forecast by Type (2018-2025)
    • 14.3.3 Global Monoclonal Antibodies Price Forecast by Type (2018-2025)
  • 14.4 Global Monoclonal Antibodies Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix

  • 16.1 Methodology/Research Approach
    • 16.1.1 Research Programs/Design
    • 16.1.2 Market Size Estimation
    • 16.1.3 Market Breakdown and Data Triangulation
  • 16.2 Data Source
    • 16.2.1 Secondary Sources
    • 16.2.2 Primary Sources
  • 16.3 Disclaimer

List of Tables and Figures

  • Figure Product Picture of Monoclonal Antibodies
  • Figure Global Monoclonal Antibodies Sales Volume Comparison (MT) by Type (2013-2025)
  • Figure Global Monoclonal Antibodies Sales Volume Market Share by Type (Product Category) in 2017
  • Figure Cancer Product Picture
  • Figure Autoimmune Diseases Product Picture
  • Figure Infection Product Picture
  • Figure Hematological Diseases Product Picture
  • Figure Others Product Picture
  • Figure Global Monoclonal Antibodies Sales Comparison (MT) by Application (2013-2025)
  • Figure Global Sales Market Share of Monoclonal Antibodies by Application in 2017
  • Figure Oncology Examples
  • Table Key Downstream Customer in Oncology
  • Figure Autoimmune and inflammatory diseases Examples
  • Table Key Downstream Customer in Autoimmune and inflammatory diseases
  • Figure Respiratory diseases Examples
  • Table Key Downstream Customer in Respiratory diseases
  • Figure Ophthalmology Examples
  • Table Key Downstream Customer in Ophthalmology
  • Figure Global Monoclonal Antibodies Market Size (Million USD) by Regions (2013-2025)
  • Figure United States Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2025)
  • Figure Europe Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2025)
  • Figure China Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2025)
  • Figure Japan Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2025)
  • Figure Southeast Asia Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2025)
  • Figure India Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2025)
  • Figure Global Monoclonal Antibodies Sales Volume (MT) and Growth Rate (2013-2025)
  • Figure Global Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2025)
  • Figure Global Market Major Players Monoclonal Antibodies Sales Volume (MT) (2013-2018)
  • Table Global Monoclonal Antibodies Sales (MT) of Key Players/Suppliers (2013-2018)
  • Table Global Monoclonal Antibodies Sales Share by Players/Suppliers (2013-2018)
  • Figure 2017 Monoclonal Antibodies Sales Share by Players/Suppliers
  • Figure 2017 Monoclonal Antibodies Sales Share by Players/Suppliers
  • Figure Global Monoclonal Antibodies Revenue (Million USD) by Players/Suppliers (2013-2018)
  • Table Global Monoclonal Antibodies Revenue (Million USD) by Players/Suppliers (2013-2018)
  • Table Global Monoclonal Antibodies Revenue Share by Players/Suppliers (2013-2018)
  • Table 2017 Global Monoclonal Antibodies Revenue Share by Players
  • Table 2017 Global Monoclonal Antibodies Revenue Share by Players
  • Table Global Monoclonal Antibodies Sales (MT) and Market Share by Type (2013-2018)
  • Table Global Monoclonal Antibodies Sales Share (MT) by Type (2013-2018)
  • Figure Sales Market Share of Monoclonal Antibodies by Type (2013-2018)
  • Figure Global Monoclonal Antibodies Sales Growth Rate by Type (2013-2018)
  • Table Global Monoclonal Antibodies Revenue (Million USD) and Market Share by Type (2013-2018)
  • Table Global Monoclonal Antibodies Revenue Share by Type (2013-2018)
  • Figure Revenue Market Share of Monoclonal Antibodies by Type (2013-2018)
  • Figure Global Monoclonal Antibodies Revenue Growth Rate by Type (2013-2018)
  • Table Global Monoclonal Antibodies Sales Volume (MT) and Market Share by Region (2013-2018)
  • Table Global Monoclonal Antibodies Sales Share by Region (2013-2018)
  • Figure Sales Market Share of Monoclonal Antibodies by Region (2013-2018)
  • Figure Global Monoclonal Antibodies Sales Growth Rate by Region in 2017
  • Table Global Monoclonal Antibodies Revenue (Million USD) and Market Share by Region (2013-2018)
  • Table Global Monoclonal Antibodies Revenue Share (%) by Region (2013-2018)
  • Figure Revenue Market Share of Monoclonal Antibodies by Region (2013-2018)
  • Figure Global Monoclonal Antibodies Revenue Growth Rate by Region in 2017
  • Table Global Monoclonal Antibodies Revenue (Million USD) and Market Share by Region (2013-2018)
  • Table Global Monoclonal Antibodies Revenue Share (%) by Region (2013-2018)
  • Figure Revenue Market Share of Monoclonal Antibodies by Region (2013-2018)
  • Figure Global Monoclonal Antibodies Revenue Market Share by Region in 2017
  • Table Global Monoclonal Antibodies Sales Volume (MT) and Market Share by Application (2013-2018)
  • Table Global Monoclonal Antibodies Sales Share (%) by Application (2013-2018)
  • Figure Sales Market Share of Monoclonal Antibodies by Application (2013-2018)
  • Figure Global Monoclonal Antibodies Sales Market Share by Application (2013-2018)
  • Figure United States Monoclonal Antibodies Sales (MT) and Growth Rate (2013-2018)
  • Figure United States Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2018)
  • Figure United States Monoclonal Antibodies Sales Price (USD/Kg) Trend (2013-2018)
  • Table United States Monoclonal Antibodies Sales Volume (MT) by Players (2013-2018)
  • Table United States Monoclonal Antibodies Sales Volume Market Share by Players (2013-2018)
  • Figure United States Monoclonal Antibodies Sales Volume Market Share by Players in 2017
  • Table United States Monoclonal Antibodies Sales Volume (MT) by Type (2013-2018)
  • Table United States Monoclonal Antibodies Sales Volume Market Share by Type (2013-2018)
  • Figure United States Monoclonal Antibodies Sales Volume Market Share by Type in 2017
  • Table United States Monoclonal Antibodies Sales Volume (MT) by Application (2013-2018)
  • Table United States Monoclonal Antibodies Sales Volume Market Share by Application (2013-2018)
  • Figure United States Monoclonal Antibodies Sales Volume Market Share by Application in 2017
  • Figure Europe Monoclonal Antibodies Sales (MT) and Growth Rate (2013-2018)
  • Figure Europe Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2018)
  • Figure Europe Monoclonal Antibodies Sales Price (USD/Kg) Trend (2013-2018)
  • Table Europe Monoclonal Antibodies Sales Volume (MT) by Players (2013-2018)
  • Table Europe Monoclonal Antibodies Sales Volume Market Share by Players (2013-2018)
  • Figure Europe Monoclonal Antibodies Sales Volume Market Share by Players in 2017
  • Table Europe Monoclonal Antibodies Sales Volume (MT) by Type (2013-2018)
  • Table Europe Monoclonal Antibodies Sales Volume Market Share by Type (2013-2018)
  • Figure Europe Monoclonal Antibodies Sales Volume Market Share by Type in 2017
  • Table Europe Monoclonal Antibodies Sales Volume (MT) by Application (2013-2018)
  • Table Europe Monoclonal Antibodies Sales Volume Market Share by Application (2013-2018)
  • Figure Europe Monoclonal Antibodies Sales Volume Market Share by Application in 2017
  • Figure China Monoclonal Antibodies Sales (MT) and Growth Rate (2013-2018)
  • Figure China Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2018)
  • Figure China Monoclonal Antibodies Sales Price (USD/Kg) Trend (2013-2018)
  • Table China Monoclonal Antibodies Sales Volume (MT) by Players (2013-2018)
  • Table China Monoclonal Antibodies Sales Volume Market Share by Players (2013-2018)
  • Figure China Monoclonal Antibodies Sales Volume Market Share by Players in 2017
  • Table China Monoclonal Antibodies Sales Volume (MT) by Type (2013-2018)
  • Table China Monoclonal Antibodies Sales Volume Market Share by Type (2013-2018)
  • Figure China Monoclonal Antibodies Sales Volume Market Share by Type in 2017
  • Table China Monoclonal Antibodies Sales Volume (MT) by Application (2013-2018)
  • Table China Monoclonal Antibodies Sales Volume Market Share by Application (2013-2018)
  • Figure China Monoclonal Antibodies Sales Volume Market Share by Application in 2017
  • Figure Japan Monoclonal Antibodies Sales (MT) and Growth Rate (2013-2018)
  • Figure Japan Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2018)
  • Figure Japan Monoclonal Antibodies Sales Price (USD/Kg) Trend (2013-2018)
  • Table Japan Monoclonal Antibodies Sales Volume (MT) by Players (2013-2018)
  • Table Japan Monoclonal Antibodies Sales Volume Market Share by Players (2013-2018)
  • Figure Japan Monoclonal Antibodies Sales Volume Market Share by Players in 2017
  • Table Japan Monoclonal Antibodies Sales Volume (MT) by Type (2013-2018)
  • Table Japan Monoclonal Antibodies Sales Volume Market Share by Type (2013-2018)
  • Figure Japan Monoclonal Antibodies Sales Volume Market Share by Type in 2017
  • Table Japan Monoclonal Antibodies Sales Volume (MT) by Application (2013-2018)
  • Table Japan Monoclonal Antibodies Sales Volume Market Share by Application (2013-2018)
  • Figure Japan Monoclonal Antibodies Sales Volume Market Share by Application in 2017
  • Figure Southeast Asia Monoclonal Antibodies Sales (MT) and Growth Rate (2013-2018)
  • Figure Southeast Asia Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2018)
  • Figure Southeast Asia Monoclonal Antibodies Sales Price (USD/Kg) Trend (2013-2018)
  • Table Southeast Asia Monoclonal Antibodies Sales Volume (MT) by Players (2013-2018)
  • Table Southeast Asia Monoclonal Antibodies Sales Volume Market Share by Players (2013-2018)
  • Figure Southeast Asia Monoclonal Antibodies Sales Volume Market Share by Players in 2017
  • Table Southeast Asia Monoclonal Antibodies Sales Volume (MT) by Type (2013-2018)
  • Table Southeast Asia Monoclonal Antibodies Sales Volume Market Share by Type (2013-2018)
  • Figure Southeast Asia Monoclonal Antibodies Sales Volume Market Share by Type in 2017
  • Table Southeast Asia Monoclonal Antibodies Sales Volume (MT) by Application (2013-2018)
  • Table Southeast Asia Monoclonal Antibodies Sales Volume Market Share by Application (2013-2018)
  • Figure Southeast Asia Monoclonal Antibodies Sales Volume Market Share by Application in 2017
  • Figure India Monoclonal Antibodies Sales (MT) and Growth Rate (2013-2018)
  • Figure India Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2018)
  • Figure India Monoclonal Antibodies Sales Price (USD/Kg) Trend (2013-2018)
  • Table India Monoclonal Antibodies Sales Volume (MT) by Players (2013-2018)
  • Table India Monoclonal Antibodies Sales Volume Market Share by Players (2013-2018)
  • Figure India Monoclonal Antibodies Sales Volume Market Share by Players in 2017
  • Table India Monoclonal Antibodies Sales Volume (MT) by Type (2013-2018)
  • Table India Monoclonal Antibodies Sales Volume Market Share by Type (2013-2018)
  • Figure India Monoclonal Antibodies Sales Volume Market Share by Type in 2017
  • Table India Monoclonal Antibodies Sales Volume (MT) by Application (2013-2018)
  • Table India Monoclonal Antibodies Sales Volume Market Share by Application (2013-2018)
  • Figure India Monoclonal Antibodies Sales Volume Market Share by Application in 2017
  • Table AbbVie Basic Information List
  • Table AbbVie Monoclonal Antibodies Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
  • Figure AbbVie Monoclonal Antibodies Sales Growth Rate (2013-2018)
  • Figure AbbVie Monoclonal Antibodies Sales Global Market Share (2013-2018)
  • Figure AbbVie Monoclonal Antibodies Revenue Global Market Share (2013-2018)
  • Table Roche Basic Information List
  • Table Roche Monoclonal Antibodies Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
  • Figure Roche Monoclonal Antibodies Sales Growth Rate (2013-2018)
  • Figure Roche Monoclonal Antibodies Sales Global Market Share (2013-2018)
  • Figure Roche Monoclonal Antibodies Revenue Global Market Share (2013-2018)
  • Table Johnson & Johnson Basic Information List
  • Table Johnson & Johnson Monoclonal Antibodies Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
  • Figure Johnson & Johnson Monoclonal Antibodies Sales Growth Rate (2013-2018)
  • Figure Johnson & Johnson Monoclonal Antibodies Sales Global Market Share (2013-2018
  • Figure Johnson & Johnson Monoclonal Antibodies Revenue Global Market Share (2013-2018)
  • Table Amgen Basic Information List
  • Table Amgen Monoclonal Antibodies Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
  • Figure Amgen Monoclonal Antibodies Sales Growth Rate (2013-2018)
  • Figure Amgen Monoclonal Antibodies Sales Global Market Share (2013-2018)
  • Figure Amgen Monoclonal Antibodies Revenue Global Market Share (2013-2018)
  • Table Merck Basic Information List
  • Table Merck Monoclonal Antibodies Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
  • Figure Merck Monoclonal Antibodies Sales Growth Rate (2013-2018)
  • Figure Merck Monoclonal Antibodies Sales Global Market Share (2013-2018)
  • Figure Merck Monoclonal Antibodies Revenue Global Market Share (2013-2018)
  • Table BMS Basic Information List
  • Table BMS Monoclonal Antibodies Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
  • Figure BMS Monoclonal Antibodies Sales Growth Rate (2013-2018)
  • Figure BMS Monoclonal Antibodies Sales Global Market Share (2013-2018
  • Figure BMS Monoclonal Antibodies Revenue Global Market Share (2013-2018)
  • Table Eli Lilly Basic Information List
  • Table Eli Lilly Monoclonal Antibodies Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
  • Figure Eli Lilly Monoclonal Antibodies Sales Growth Rate (2013-2018)
  • Figure Eli Lilly Monoclonal Antibodies Sales Global Market Share (2013-2018)
  • Figure Eli Lilly Monoclonal Antibodies Revenue Global Market Share (2013-2018)
  • Table Formation Biologics Basic Information List
  • Table Formation Biologics Monoclonal Antibodies Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
  • Figure Formation Biologics Monoclonal Antibodies Sales Growth Rate (2013-2018)
  • Figure Formation Biologics Monoclonal Antibodies Sales Global Market Share (2013-2018
  • Figure Formation Biologics Monoclonal Antibodies Revenue Global Market Share (2013-2018)
  • Table Genmab Basic Information List
  • Table Genmab Monoclonal Antibodies Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
  • Figure Genmab Monoclonal Antibodies Sales Growth Rate (2013-2018)
  • Figure Genmab Monoclonal Antibodies Sales Global Market Share (2013-2018)
  • Figure Genmab Monoclonal Antibodies Revenue Global Market Share (2013-2018)
  • Table GlaxoSmithKline Basic Information List
  • Table GlaxoSmithKline Monoclonal Antibodies Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
  • Figure GlaxoSmithKline Monoclonal Antibodies Sales Growth Rate (2013-2018)
  • Figure GlaxoSmithKline Monoclonal Antibodies Sales Global Market Share (2013-2018)
  • Figure GlaxoSmithKline Monoclonal Antibodies Revenue Global Market Share (2013-2018)
  • Table Human Genome Sciences Basic Information List
  • Table mmunogen Basic Information List
  • Table MedImmune Basic Information List
  • Table Novartis Basic Information List
  • Table Pfizer Basic Information List
  • Table Seattle Genetics Basic Information List
  • Table Stemcentrx Basic Information List
  • Table Synthon Biopharmaceuticals Basic Information List
  • Table Takeda Basic Information List
  • Table Teva Basic Information List
  • Table Production Base and Market Concentration Rate of Raw Material
  • Figure Price Trend of Key Raw Materials
  • Table Key Suppliers of Raw Materials
  • Figure Manufacturing Cost Structure of Monoclonal Antibodies
  • Figure Manufacturing Process Analysis of Monoclonal Antibodies
  • Figure Monoclonal Antibodies Industrial Chain Analysis
  • Table Raw Materials Sources of Monoclonal Antibodies Major Players in 2017
  • Table Major Buyers of Monoclonal Antibodies
  • Table Distributors/Traders List
  • Figure Global Monoclonal Antibodies Sales Volume (MT) and Growth Rate Forecast (2018-2025)
  • Figure Global Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2018-2025)
  • Figure Global Monoclonal Antibodies Price (USD/Kg) and Trend Forecast (2018-2025)
  • Table Global Monoclonal Antibodies Sales Volume (MT) Forecast by Regions (2018-2025)
  • Figure Global Monoclonal Antibodies Sales Volume Market Share Forecast by Regions (2018-2025)
  • Figure Global Monoclonal Antibodies Sales Volume Market Share Forecast by Regions in 2025
  • Table Global Monoclonal Antibodies Revenue (Million USD) Forecast by Regions (2018-2025)
  • Figure Global Monoclonal Antibodies Revenue Market Share Forecast by Regions (2018-2025)
  • Figure Global Monoclonal Antibodies Revenue Market Share Forecast by Regions in 2025
  • Figure United States Monoclonal Antibodies Sales Volume (MT) and Growth Rate Forecast (2018-2025)
  • Figure United States Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2018-2025)
  • Figure Europe Monoclonal Antibodies Sales Volume (MT) and Growth Rate Forecast (2018-2025)
  • Figure Europe Monoclonal Antibodies Revenue and Growth Rate Forecast (2018-2025)
  • Figure China Monoclonal Antibodies Sales Volume (MT) and Growth Rate Forecast (2018-2025)
  • Figure China Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2018-2025)
  • Figure Japan Monoclonal Antibodies Sales Volume (MT) and Growth Rate Forecast (2018-2025)
  • Figure Japan Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2018-2025)
  • Figure Southeast Asia Monoclonal Antibodies Sales Volume (MT) and Growth Rate Forecast (2018-2025)
  • Figure Southeast Asia Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2018-2025)
  • Figure India Monoclonal Antibodies Sales Volume (MT) and Growth Rate Forecast (2018-2025)
  • Figure India Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2018-2025)
  • Table Global Monoclonal Antibodies Sales (MT) Forecast by Type (2018-2025)
  • Figure Global Monoclonal Antibodies Sales Volume Market Share Forecast by Type (2018-2025)
  • Table Global Monoclonal Antibodies Revenue (Million USD) Forecast by Type (2018-2025)
  • Figure Global Monoclonal Antibodies Revenue Market Share Forecast by Type (2018-2025)
  • Table Global Monoclonal Antibodies Price (USD/Kg) Forecast by Type (2018-2025)
  • Table Global Monoclonal Antibodies Sales (MT) Forecast by Application (2018-2025)
  • Figure Global Monoclonal Antibodies Sales Market Share Forecast by Application (2018-2025)
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources

단클론 항체 관련자료

TOP
회사소개 이용약관 개인정보 처리방침 사이트맵

© Copyright 2011-2018, Global Information, Inc. All rights reserved.